Enveric corrects reverse stock split effective date to January 29, 2025

Enveric Biosciences, Inc.

Reverse stock split of 1-for-15 will begin trading on Nasdaq Capital Market on January 29, 2025 (previously January 27).
Post-split CUSIP number: 29405E 406; trading symbol remains ENVB.
Amendment filed solely to correct the effective date; original split approved by board and stockholders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.